ELRANATAMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 15300GMP | ELRANATAMAB Elranatamab 44 mg/1.1 mL injection, 1.1 mL vial (PI, CMI) |
1 | 1 | 1 | $3,658.93 | $25.00 | $25.00 |
| Available brands | |||||||
| Elrexfio |
ELRANATAMAB
| Source | Section 100 (CT) |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 15301HMP | ELRANATAMAB Elranatamab 44 mg/1.1 mL injection, 1.1 mL vial (PI, CMI) |
1 | 1 | 1 | $3,496.00 | $25.00 | $25.00 |
| Available brands | |||||||
| Elrexfio |
- Legend
- MPMedical Practitioner




